Search

everythinglearnresearchcommunity

for

Search:↓

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Artificial sebum L closely mimics human sebum for drug delivery research.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Using topical minoxidil for baldness can cause heart problems, especially in those with heart disease.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Long-term minoxidil use can cause pseudoacromegaly, but stopping it improves symptoms.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

Herbal extracts and platelet-rich plasma together may help increase hair growth by making certain cells grow more, through specific cell growth pathways.

Aging in hair follicle stem cells leads to hair graying, thinning, and loss.

Oral minoxidil shows promise in treating monilethrix-related hair loss.

Sweat gland stem cells help maintain glands, aid wound healing, and can regenerate skin structures.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Cell-based therapies using dermal papilla cells and adipocyte lineage cells show potential for hair regeneration.

Oral minoxidil helps hair regrowth in 80% of alopecia patients, but only 18% see cosmetic improvement.

Microneedles with enhancer effectively promote hair growth and increase hair density.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Ultrasound shows 80% of Hidradenitis Suppurativa patients have abnormal hair tracts that may worsen the condition.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Oleic acid nanovesicles improve minoxidil absorption in hair follicles for alopecia treatment.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

Chitosan-coated dutasteride nanocapsules improve hair treatment, and physical stimulation boosts effectiveness.